Conversely, treatment with shikonin was shown to trigger ferroptosis by inducing heme oxygenase 1 (HMOX1) expression, thereby sensitizing ovarian cancer cells to cisplatin [43]. The gene discussed is HMOX1; the disease is ovarian cancer.